Salvanou, E.-A.; Apostolopoulou, A.; Xanthopoulos, S.; Koelewijn, S.; van Overeem, P.; Laurent, G.; Bazzi, R.; Denat, F.; Roux, S.; Bouziotis, P.
161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer. Materials 2025, 18, 248.
https://doi.org/10.3390/ma18020248
AMA Style
Salvanou E-A, Apostolopoulou A, Xanthopoulos S, Koelewijn S, van Overeem P, Laurent G, Bazzi R, Denat F, Roux S, Bouziotis P.
161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer. Materials. 2025; 18(2):248.
https://doi.org/10.3390/ma18020248
Chicago/Turabian Style
Salvanou, Evangelia-Alexandra, Adamantia Apostolopoulou, Stavros Xanthopoulos, Stuart Koelewijn, Philippe van Overeem, Gautier Laurent, Rana Bazzi, Franck Denat, Stéphane Roux, and Penelope Bouziotis.
2025. "161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer" Materials 18, no. 2: 248.
https://doi.org/10.3390/ma18020248
APA Style
Salvanou, E.-A., Apostolopoulou, A., Xanthopoulos, S., Koelewijn, S., van Overeem, P., Laurent, G., Bazzi, R., Denat, F., Roux, S., & Bouziotis, P.
(2025). 161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer. Materials, 18(2), 248.
https://doi.org/10.3390/ma18020248
